Zynerba Pharmaceuticals - 4 Year Stock Split History | ZYNE

Stock split history for Zynerba Pharmaceuticals since 2015. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Zynerba Pharmaceuticals Annual Stock Splits
Zynerba Pharmaceuticals Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.069B $0.000B
Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates which are in clinical trial stage include ZYN002 and ZYN001 synthetic transdermal cannabinoid therapeutics for indications including refractory epilepsy, Fragile X syndrome, osteoarthritis, fibromyalgia and peripheral neuropathic pain. Zynerba Pharmaceuticals, Inc. is headquartered in Devon, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $54.040B 9.28
Teva Pharmaceutical Industries (TEVA) Israel $19.138B 5.86
Mylan (MYL) United Kingdom $15.258B 6.28
Bausch Health Cos (BHC) Canada $8.076B 5.85
Dr Reddy's Laboratories (RDY) India $6.150B 24.53
Supernus Pharmaceuticals (SUPN) United States $1.988B 18.84
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.719B 2.87
Amphastar Pharmaceuticals (AMPH) United States $1.011B 109.70
Homology Medicines (FIXX) United States $0.857B 0.00
Assembly Biosciences (ASMB) United States $0.535B 0.00
CymaBay Therapeutics (CBAY) United States $0.531B 0.00
Akorn (AKRX) United States $0.451B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.415B 0.00
Voyager Therapeutics (VYGR) United States $0.269B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.247B 0.00
Sol-Gel Technologies (SLGL) Israel $0.110B 0.00
Teligent (TLGT) United States $0.094B 0.00
Acasti Pharma (ACST) Canada $0.087B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.056B 0.00
Evoke Pharma (EVOK) United States $0.049B 0.00
Agile Therapeutics (AGRX) United States $0.031B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.006B 0.00